Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.
Federal judge dismisses longstanding suit over Bristol Myers’ $74B Celgene buyout
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS